TIZONA THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 Jun 2020)
What this means for you
This application is over — abandoned 29 Jun 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86658131
- Mark type
- Stylized text
- Filed
- 10 Jun 2015
- Published for opposition
- 08 Dec 2015
- Abandoned
- 29 Jun 2020
- Attorney of record
- Sharon Smith
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use in the treatment of cancer and autoimmune diseases; pharmaceutical preparations and compounds for modulation of the immune system and the tumor microenvironment
- Class 042 — Scientific and technological services: consulting services in the field of pharmaceutical research and development; research and development of pharmaceutical preparations and medicines for others
Owner
- TIZONA THERAPEUTICS, INC., CAMBRIDGE, MA, US
- Vesuvius Pharmaceuticals, Inc., Cambridge, MA, US
- Vesuvius Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 29 Jun 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Jun 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Jun 2020 — CORRECTED NOA E-MAILED
- 24 Jun 2020 — DIVISIONAL PROCESSING COMPLETE
- 31 Jan 2020 — DIVISIONAL REQUEST RECEIVED
- 11 Feb 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Feb 2019 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 31 Jan 2019 — TEAS REQUEST TO DIVIDE RECEIVED
- 09 Aug 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2018 — SOU EXTENSION 5 GRANTED
- 01 Aug 2018 — SOU EXTENSION 5 FILED
- 08 Aug 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Aug 2018 — SOU TEAS EXTENSION RECEIVED
- 02 Feb 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jan 2018 — SOU EXTENSION 4 GRANTED